TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% - Here's Why …

Dec 31, 2024 · The Goldman Sachs Group boosted their target price on TG Therapeutics from $20.00 to $22.00 and gave the company a "neutral" rating in a research report on Tuesday, November 5th. JPMorgan Chase & Co. raised their price target on TG Therapeutics from …

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% - Here's Why …

2 weeks from now

marketbeat.com

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Stock Price Down 2.4% – What’s …

2 weeks from now

Jan 2, 2025 · TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report)’s stock price dropped 2.4% during trading on Tuesday . The stock traded as low as $30.61 and last traded at $30.68. …

etfdailynews.com

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% – Here’s …

2 weeks from now

Dec 31, 2024 · TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) fell 2.4% during trading on Tuesday . The stock traded as low as $30.61 and last traded at $30.68. 366,002 …

americanbankingnews.com

24%
OFF

TG Therapeutics (TGTX) Stock Price, News & Analysis - MarketBeat

2 weeks from now

5 days ago · Read more about TG Therapeutics' stock forecast and price target. Earnings and Valuation 1.9 / 5 Proj. Earnings Growth 488.24%. Earnings Growth. Earnings for TG …

marketbeat.com

9%
OFF

TG Therapeutics (NASDAQ:TGTX) Shares Down 2.9% - Time To …

2 weeks from now

Jan 6, 2025 · Shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) traded down 2.9% on Monday . The stock traded as low as $29.01 and last traded at $29.19. 195,725 …

marketbeat.com

4%
OFF

Summary - TGTX - NASDAQ - Weiss Ratings

2 weeks from now

Dec 31, 2024 · TG Therapeutics (NASDAQ:TGTX) Stock Price Down 2.4% and#8211; Should You Sell? 12/31/2024 - Ticker Report. TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% …

weissratings.com

40%
OFF

What's Going On With TG Therapeutics Stock Today?

2 weeks from now

Aug 1, 2023 · TG Therapeutics Inc (NASDAQ:TGTX) shares are down over 40%. The company reported Q2 FY23 Briumvi net sales of $16 million in the U.S., with total net revenue of …

businessinsider.com

$49
OFF

TG Therapeutics Stock Price | TGTX Stock Quote, News, And …

2 weeks from now

4 days ago · The latest TG Therapeutics stock prices, stock quotes, news, and TGTX history to help you invest and trade smarter. ... Price 05/02/24 H.C. Wainwright & Co. Maintained Buy $49 gut 05/02/24 ...

businessinsider.com

4%
OFF

TG Therapeutics - TGTX - Stock Price & News | The Motley Fool

2 weeks from now

Real time TG Therapeutics (TGTX) stock price quote, stock graph, news & analysis. ... TG Therapeutics (NASDAQ: TGTX) $28.88 (0.4%) $0.11 ... +81.24% +12.63% ...

fool.com

50%
OFF

Why Is TG Therapeutics (TGTX) Stock Down 50% Today?

2 weeks from now

Aug 1, 2023 · At the moment, analysts peg TGTX stock as a consensus moderate buy with an average price target of $30.94. This figure represents upside potential of over 200%. This …

investorplace.com

$4
OFF

Why TG Therapeutics Stock Is Crashing Today - The Motley Fool

2 weeks from now

Aug 1, 2023 · NASDAQ: TGTX TG Therapeutics. Market Cap. $4B. Today's Change (%) Current Price. $28.00. Price as of January 7, 2025, 4:00 p.m. ET ... Why TG Therapeutics Stock Was …

fool.com

57%
OFF

Down 57% In A Month, Is There More Pain For TG Therapeutics …

2 weeks from now

Feb 1, 2022 · The stock price of TG Therapeutics (NASDAQ: TGTX), a commercial stage biopharmaceutical company focused on the development of novel treatments for B-cell …

nasdaq.com

05%
OFF

TG Therapeutics Stock Quote: TGTX Stock News, Quotes, …

2 weeks from now

4 days ago · TGTX, TG Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines ... TG Therapeutics (TGTX) ... STOCK/COMPANY DATA FOR TGTX . Stock Data. Today's Range; 27.71 - 28.96; 52-Week Range; 12.84 - 36.84; Price % Chg. YTD-4.05%; Price % Chg. Last 4 Weeks ...

investors.com

$45
OFF

Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts

2 weeks from now

14 hours ago · In the assessment of 12-month price targets, analysts unveil insights for TG Therapeutics, presenting an average target of $45.0, a high estimate of $55.00, and a low …

benzinga.com

773%
OFF

TGTX Stock Price And Chart | ChartExchange

2 weeks from now

Dec 6, 2024 · TGTX Stock Summary. TG Therapeutics Inc (NASDAQ:TGTX) stock price today is $33.91, and today's volume is 1,297,098. TGTX is up 0.773% today. The 30 day average volume is 2,521,270. TGTX market cap is 5.279B with 155,665,334 shares outstanding.

chartexchange.com

4%
OFF

TG Therapeutics (NASDAQ:TGTX) Stock Price Down 2.4% – Should …

2 weeks from now

Dec 31, 2024 · TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report)’s stock price fell 2.4% during trading on Tuesday . The company traded as low as $30.61 and last traded at $30.68. …

tickerreport.com

$103
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TG Therapeutics expects fourth-quarter BRIUMVI net product revenue in the U.S. to be $103.6 million. TG Therapeutics says it expects to report a 2024 year-end cash position of …

benzinga.com

5%
OFF

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

2 weeks from now

14 hours ago · TG Therapeutics (TGTX Quick Quote TGTX - Free Report) shares ended the last trading session 7.5% higher at $29.74. The jump came on an impressive volume with a higher …

zacks.com

8%
OFF

TG Therapeutics Stock Rises On Strong Q4 And Full-year Revenue

2 weeks from now

1 day ago · Investing.com -- TG Therapeutics, Inc. (NASDAQ: NASDAQ:TGTX) shares climbed 8% after the company reported preliminary net product revenue for the fourth quarter and full …

investing.com

$40.67
OFF

TG Therapeutics (TGTX) Stock Forecast And Price Target 2025

2 weeks from now

1 day ago · According to the 6 analysts' twelve-month price targets for TG Therapeutics, the average price target is $40.67. The highest price target for TGTX is $55.00, while the lowest …

marketbeat.com

$525
OFF

TG Therapeutics Stock Gains On Briumvi Sales (TGTX:NASDAQ)

2 weeks from now

1 day ago · According to TG Therapeutics (NASDAQ:TGTX), the intravenously delivered treatment is expected to generate about $525M in net product revenue this year from the U.S., …

seekingalpha.com

FAQs about TG Therapeutics (NASDAQ:TGTX) Trading Down 2.4% - Here's Why … Coupon?

What happened to TG Therapeutics (tgtx) stock?

TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report)’s stock price dropped 2.4% during trading on Tuesday . The stock traded as low as $30.61 and last traded at $30.68. Approximately 366,002 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 3,526,031 shares. The stock had previously closed at $31.45. ...

Is TG Therapeutics a good stock to buy?

StockNews.com lowered TG Therapeutics from a “hold” rating to a “sell” rating in a report on Sunday, December 22nd. HC Wainwright upped their price objective on shares of TG Therapeutics from $49.00 to $55.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. ...

What is tgtx's current price target?

TGTX's current price target is $40.67. Learn why top analysts are making this stock forecast for TG Therapeutics at MarketBeat. ...

Where can I buy shares of TG Therapeutics?

Shares of TGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of TG Therapeutics own? ...

Who owns TG Therapeutics Inc?

Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC. TGTX | Complete TG Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

What is the price target for TG Therapeutics (tgtx)?

The highest price target for TGTX is $55.00, while the lowest price target for TGTX is $22.00. The average price target represents a forecasted upside of 18.22% from the current price of $34.40. Enter your email address to receive the latest news and analysts' ratings for TG Therapeutics and its competitors. ...